Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 27;22(17):9294.
doi: 10.3390/ijms22179294.

The Role of Epigenetic Factors in Psoriasis

Klaudia Dopytalska  1 , Piotr Ciechanowicz  1 , Kacper Wiszniewski  1 , Elżbieta Szymańska  1 , Irena Walecka  1
Affiliations
Review

The Role of Epigenetic Factors in Psoriasis

Klaudia Dopytalska et al. Int J Mol Sci. .

Abstract

Psoriasis is a chronic, systemic, immune-mediated disease with an incidence of approximately 2%. The pathogenesis of the disease is complex and not yet fully understood. Genetic factors play a significant role in the pathogenesis of the disease. In predisposed individuals, multiple trigger factors may contribute to disease onset and exacerbations of symptoms. Environmental factors (stress, infections, certain medications, nicotinism, alcohol, obesity) play a significant role in the pathogenesis of psoriasis. In addition, epigenetic mechanisms are considered result in modulation of individual gene expression and an increased likelihood of the disease. Studies highlight the significant role of epigenetic factors in the etiology and pathogenesis of psoriasis. Epigenetic mechanisms in psoriasis include DNA methylation, histone modifications and non-coding RNAs. Epigenetic mechanisms induce gene expression changes under the influence of chemical modifications of DNA and histones, which alter chromatin structure and activate transcription factors of selected genes, thus leading to translation of new mRNA without affecting the DNA sequence. Epigenetic factors can regulate gene expression at the transcriptional (via histone modification, DNA methylation) and posttranscriptional levels (via microRNAs and long non-coding RNAs). This study aims to present and discuss the different epigenetic mechanisms in psoriasis based on a review of the available literature.

Keywords: DNA methylation; dermatology; epigenetics; non-coding RNA; psoriasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Epigenetic modifications in psoriasis: DNA methylation, histone modifications and non-coding RNAs.
See this image and copyright information in PMC

References

    1. Griffiths C.E.M., Armstrong A.W., Gudjonsson J.E., Barker J.N.W.N. Psoriasis. Lancet. 2021;397:1301–1315. doi: 10.1016/S0140-6736(20)32549-6. - DOI - PubMed
    1. Parisi R., Iskandar I.Y.K., Kontopantelis E., Augustin M., Griffiths C.E.M., Ashcroft D. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ. 2020;369:m1590. doi: 10.1136/bmj.m1590. - DOI - PMC - PubMed
    1. Armstrong A.W., Read C. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020;323:1945–1960. doi: 10.1001/jama.2020.4006. - DOI - PubMed
    1. Takeshita J., Grewal S., Langan S., Mehta N.N., Ogdie A., Van Voorhees A.S., Gelfand J. Psoriasis and comorbid diseases: Epidemiology. J. Am. Acad. Dermatol. 2017;76:377–390. doi: 10.1016/j.jaad.2016.07.064. - DOI - PMC - PubMed
    1. Amin M., Lee E., Tsai T., Wu J. Psoriasis and Co-morbidity. Acta Derm. Venereol. 2020;100:81–87. doi: 10.2340/00015555-3387. - DOI - PMC - PubMed